91 filings
Page 4 of 5
8-K
lgmg9rm1mez6glpb7 xb
19 Jun 17
Entry into a Material Definitive Agreement
12:00am
8-K
83w9 ic3j
14 Jun 17
Viking Therapeutics Announces $4.3 Million Registered Direct Offering
12:00am
8-K
cssvn77
24 May 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
94s w2zpgsilgv0m
10 May 17
Viking Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update
12:00am
8-K
qtnqk
21 Mar 17
Viking Therapeutics Reports Fourth Quarter and Year-End 2016 Financial Results and Provides Corporate Update
12:00am
8-K
nflmtxl8iijdh125u5l
14 Feb 17
Entry into a Material Definitive Agreement
12:00am
8-K
x4z6qa z94
10 Nov 16
Viking Therapeutics Reports Third Quarter 2016 Financial Results and Provides Corporate Update
12:00am
8-K
jbcbbapo
4 Oct 16
Novel Oral Thyroid Receptor Agonist has Unique Potential to Simultaneously Improve Plasma Lipid Profile and Reduce Hepatic Steatosis
12:00am
8-K
nzdvvf6feyi2i
19 Sep 16
Departure of Directors or Certain Officers
12:00am
8-K
7pghloa3rf
25 Aug 16
Viking Therapeutics Enters Into $12.5 Million Common Stock Purchase Agreement with Aspire Capital
12:00am
8-K
4lq50tr
10 Aug 16
Viking Therapeutics Reports Second Quarter 2016 Financial Results and Provides Corporate Update
12:00am
8-K
7znl4vld
20 Jun 16
Entry into a Material Definitive Agreement
12:00am
8-K
rqw1zu7c6nnof6w7bqrg
27 May 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
xjm4t 6p1y8rd5xm
10 May 16
Viking Therapeutics Reports First Quarter 2016 Financial Results and Provides Corporate Update
12:00am
8-K
z1n9whb2j42kuq3zg
2 May 16
Viking Therapeutics Announces Full Exercise of Over-Allotment Option
12:00am
8-K
7l6odmqq
14 Apr 16
Entry into a Material Definitive Agreement
12:00am
8-K
ulkto asv
13 Apr 16
Viking Therapeutics Announces Closing of Public Offering of Common Stock and Warrants
12:00am
8-K
q7gb3y33kqwures8y9i7
8 Apr 16
Viking Therapeutics Announces Pricing of Public Offering of Common Stock and Warrants
12:00am
8-K
qb94 vyftqfx33a
15 Mar 16
Departure of Directors or Certain Officers
12:00am
8-K
gk6tuxp4
8 Mar 16
Viking Therapeutics Reports Fourth Quarter and Year-End 2015 Financial Results and Provides Corporate Update
12:00am